Think You Know the Latest ASH Leukemia & Lymphoma Research?
Do you remember the leukemia and lymphoma research presented at ASH? Test your knowledge now and see how you rank!
Feb 22, 2024
MEETING BRIEF
65th ASH Annual Meeting: Leukemia & Lymphoma
The latest news from the 65th ASH Annual Meeting focused on leukemia and lymphoma, including abstracts, featured articles, and conference information.
65th ASH Annual Meeting: Leukemia & Lymphoma Curated eBook
65th ASH Annual Meeting: Leukemia & Lymphoma Curated eBook
A curated eBook featuring 65th ASH Annual Meeting leukemia and lymphoma-focused studies, findings, and expert opinions.
Patients With Acute Myeloid Leukemia & TP53 Mutation Have Lower Overall Survival, Complete Remission
Patients With Acute Myeloid Leukemia & TP53 Mutation Have Lower Overall Survival, Complete Remission
Research from ASH 2023 showed standard treatment options lack efficacy for patients who are positive for the TP53 mutation with AML.
Fatigue in Acute Leukemia & MDS Tied to Higher Hazard of Death
Fatigue in Acute Leukemia & MDS Tied to Higher Hazard of Death
Patients reporting increased fatigue have a higher hazard of death compared with those who did not after adjusting for covariates.
Meet the Trialist: Jeff Sharman, MD, on ELEVATE-TN
Meet the Trialist: Jeff Sharman, MD, on ELEVATE-TN
Treatment that includes acalabrutinib can improve progression-free survival in treatment-naïve patients with chronic lymphocytic leukemia.
Advertisement
PW QUIZ
Advertisement
Advertisement
Sandwich Treatment Model Shows Promise for Mantle Cell Lymphoma
Sandwich Treatment Model Shows Promise for Mantle Cell Lymphoma
A sandwich treatment model that includes acalabrutinib and rituximab in combination with R-DHAOx chemotherapy shows encouraging results in phase 2 trial.
Molecular MRD Guides Transplantation for NPM1 Mut AML in First Remission
Molecular MRD Guides Transplantation for NPM1 Mut AML in First Remission
The following is a summary of "Benefit of Allogeneic Transplant in 1st Complete Remission in...
Autologous Transplant Superior to CAR-T Therapy for Patients With Large B-Cell Lymphoma
Autologous Transplant Superior to CAR-T Therapy for Patients With Large B-Cell Lymphoma
The following is a summary of "Autologous Transplant (auto-HCT) Is Associated with Improved...
Acalabrutinib Lenalidomide+Rituximab Treatment Achieves High CR Rates in Patients With Follicular Lymphoma
Acalabrutinib Lenalidomide+Rituximab Treatment Achieves High CR Rates in Patients With Follicular Lymphoma
The following is a summary of "Addition of Acalabrutinib to Lenalidomide and Rituximab Induces...
EXPLORE MORE
Check Out the 65th ASH Annual Meeting Exhibit Hall
With over 275 exhibitors, the 65th ASH Annual Meeting exhibit hall is not to be missed!
Participate Virtually in the 2023 ASH Foundation Run/Walk
Sign up today for the virtual 2023 ASH Foundation Run/Walk!
Helpful Resources for Before, During & After the 65th ASH Annual Meeting
Make the most of your attendance at the 65th ASH annual meeting by utilizing these helpful resources to plan your schedule and stay informed!
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
